190 related articles for article (PubMed ID: 26878784)
1. Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models.
Kim SH; Hwang KA; Choi KC
J Nutr Biochem; 2016 Feb; 28():70-82. PubMed ID: 26878784
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer.
Lee GA; Hwang KA; Choi KC
Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962
[TBL] [Abstract][Full Text] [Related]
3. Progression of breast cancer cells was enhanced by endocrine-disrupting chemicals, triclosan and octylphenol, via an estrogen receptor-dependent signaling pathway in cellular and mouse xenograft models.
Lee HR; Hwang KA; Nam KH; Kim HC; Choi KC
Chem Res Toxicol; 2014 May; 27(5):834-42. PubMed ID: 24684733
[TBL] [Abstract][Full Text] [Related]
4. Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells.
Lee GA; Choi KC; Hwang KA
Environ Toxicol Pharmacol; 2017 Jan; 49():48-57. PubMed ID: 27902959
[TBL] [Abstract][Full Text] [Related]
5. Treatment with Phytoestrogens Reversed Triclosan and Bisphenol A-Induced Anti-Apoptosis in Breast Cancer Cells.
Lee GA; Choi KC; Hwang KA
Biomol Ther (Seoul); 2018 Sep; 26(5):503-511. PubMed ID: 29310425
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways.
Hwang KA; Park MA; Kang NH; Yi BR; Hyun SH; Jeung EB; Choi KC
Toxicol Appl Pharmacol; 2013 Nov; 272(3):637-46. PubMed ID: 23933164
[TBL] [Abstract][Full Text] [Related]
7. Methoxychlor and triclosan stimulates ovarian cancer growth by regulating cell cycle- and apoptosis-related genes via an estrogen receptor-dependent pathway.
Kim JY; Yi BR; Go RE; Hwang KA; Nam KH; Choi KC
Environ Toxicol Pharmacol; 2014 May; 37(3):1264-74. PubMed ID: 24835555
[TBL] [Abstract][Full Text] [Related]
8. Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models.
Go RE; Kim CW; Jeon SY; Byun YS; Jeung EB; Nam KH; Choi KC
Environ Toxicol; 2017 Apr; 32(4):1439-1454. PubMed ID: 27539251
[TBL] [Abstract][Full Text] [Related]
9. Growth and migration of LNCaP prostate cancer cells are promoted by triclosan and benzophenone-1 via an androgen receptor signaling pathway.
Kim SH; Hwang KA; Shim SM; Choi KC
Environ Toxicol Pharmacol; 2015 Mar; 39(2):568-76. PubMed ID: 25682003
[TBL] [Abstract][Full Text] [Related]
10. Kaempferol blocks neutrophil extracellular traps formation and reduces tumour metastasis by inhibiting ROS-PAD4 pathway.
Zeng J; Xu H; Fan PZ; Xie J; He J; Yu J; Gu X; Zhang CJ
J Cell Mol Med; 2020 Jul; 24(13):7590-7599. PubMed ID: 32427405
[TBL] [Abstract][Full Text] [Related]
11. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol.
Hung H
J Cell Physiol; 2004 Feb; 198(2):197-208. PubMed ID: 14603522
[TBL] [Abstract][Full Text] [Related]
13. Benzophenone-1 stimulated the growth of BG-1 ovarian cancer cells by cell cycle regulation via an estrogen receptor alpha-mediated signaling pathway in cellular and xenograft mouse models.
Park MA; Hwang KA; Lee HR; Yi BR; Jeung EB; Choi KC
Toxicology; 2013 Mar; 305():41-8. PubMed ID: 23328252
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
[TBL] [Abstract][Full Text] [Related]
15. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
16. Biphasic effects of kaempferol on the estrogenicity in human breast cancer cells.
Oh SM; Kim YP; Chung KH
Arch Pharm Res; 2006 May; 29(5):354-62. PubMed ID: 16756079
[TBL] [Abstract][Full Text] [Related]
17. Effect of fenhexamid and cyprodinil on the expression of cell cycle- and metastasis-related genes via an estrogen receptor-dependent pathway in cellular and xenografted ovarian cancer models.
Go RE; Kim CW; Choi KC
Toxicol Appl Pharmacol; 2015 Nov; 289(1):48-57. PubMed ID: 26344002
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
19. Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.
Sirianni R; Zolea F; Chimento A; Ruggiero C; Cerquetti L; Fallo F; Pilon C; Arnaldi G; Carpinelli G; Stigliano A; Pezzi V
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2238-50. PubMed ID: 23074235
[TBL] [Abstract][Full Text] [Related]
20. Triclocarban and triclosan promote breast cancer progression in vitro and in vivo via activating G protein-coupled estrogen receptor signaling pathways.
He TT; Li X; Ma JZ; Yang Y; Zhu S; Zeng J; Luo L; Yin YL; Cao LY
Sci Total Environ; 2024 Jun; 931():172782. PubMed ID: 38679099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]